Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Measles
Pneumococcal disease
Adults
Children
Older adults
2019
Clear all
Type of publications
NITAG documentation
(1)
Systematic reviews (SYSVAC)
(12)
Topics
Available to download in languages
Regions
Americas
(1)
Europe
(2)
Western Pacific
(1)
Countries
Diseases
Measles
(5)
Pneumococcal disease
(8)
Dengue
(2)
Diphtheria
(3)
Hepatitis A
(1)
Hepatitis B
(4)
Herpes zoster
(3)
HIV / AIDS
(1)
Human papillomavirus (HPV)
(12)
Mumps
(2)
Pertussis
(4)
Poliomyelitis
(2)
Rotavirus
(1)
Rubella
(2)
Tetanus
(3)
Tuberculosis
(1)
Varicella
(1)
Vaccine topics
Acceptance
(1)
Administration
(5)
Coverage
(4)
Economic aspects
(2)
Efficacy/effectiveness
(8)
Safety
(4)
Target population
Adults
(5)
Children
(8)
Older adults
(3)
Adolescents
(2)
All age groups
(3)
Healthcare workers
(1)
Newborn
(10)
Publication date
2019
(13)
2024
(1)
2023
(16)
2022
(21)
2021
(10)
2020
(11)
2018
(5)
2017
(12)
2016
(17)
2015
(7)
2014
(8)
2013
(5)
2012
(6)
2011
(6)
13 results found
2019
∙
McGirr, A. Iqbal, S. M. Izurieta, P. Talarico, C. Luijken, J. Redig, J. Newson, R. S.
A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines
2019
∙
Walker, E. J. MacDonald, N. E. Islam, N. Le Saux, N. Top, K. A. Fell, D. B.
Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic review
2019
∙
Leidner, A. J. Murthy, N. Chesson, H. W. Biggerstaff, M. Stoecker, C. Harris, A. M. Acosta, A. Dooling, K. Bridges, C. B.
Cost-effectiveness of adult vaccinations: A systematic review
2019
∙
Nic Lochlainn, L. M. de Gier, B. van der Maas, N. van Binnendijk, R. Strebel, P. M. Goodman, T. de Melker, H. E. Moss, W. J. Hahne, S. J. M.
Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis
2019
∙
Sings, H. L. De Wals, P. Gessner, B. D. Isturiz, R. Laferriere, C. McLaughlin, J. M. Pelton, S. Schmitt, H. J. Suaya, J. A. Jodar, L.
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies
2019
∙
Vardanjani, H. M. Borna, H. Ahmadi, A.
Effectiveness of pneumococcal conjugate vaccination against invasive pneumococcal disease among children with and those without HIV infection: a systematic review and meta-analysis
2019
∙
Mehtani, N. J. Rosman, L. Moss, W. J.
Immunogenicity and Safety of the Measles Vaccine in HIV-Infected Children: An Updated Systematic Review
2019
∙
Vadlamudi, N. K. Chen, A. Marra, F.
Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis
2019
∙
Loevinsohn, G. Rosman, L. Moss, W. J.
Measles Seroprevalence and Vaccine Responses in Human Immunodeficiency Virus-infected Adolescents and Adults: A Systematic Review
2019
∙
McLaughlin, J. M. Jiang, Q. Gessner, B. D. Swerdlow, D. L. Sings, H. L. Isturiz, R. E. Jodar, L.
Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register